Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000303
Chunk: 106

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 106
---
 other government action to close.

(c) “”
means the Securities and Exchange Commission.

(d) “”
means the Securities Exchange Act of 1934, as amended.

(e) “” means any material adverse effect on (i) the enforceability of this Note, (ii) the results of operations, assets, business
or financial condition of the Company and its Subsidiaries, taken as a whole, other than any material adverse effect that resulted primarily
from (A) any change in the United States or foreign economies or securities or financial markets in general that does not have a disproportionate
effect on the Company and its Subsidiaries, taken as a whole, (B) any change that generally affects the industry in which the Company
and its Subsidiaries operate that does not have a disproportionate effect on the Company and its Subsidiaries, taken as a whole, (C) any
change arising in connection with pandemics, earthquakes, hostilities, acts of war, sabotage or terrorism or military actions or any escalation
or material worsening of any such hostilities, acts of war, sabotage or terrorism or military actions, (D) any action taken, or omitted
to be taken, by the Holder, its affiliates or its or their respective successors and assigns with respect to the transactions contemplated
by this Note, (E) the effect of any change in applicable laws or accounting rules that does not have a disproportionate effect on the
Company and its Subsidiaries, taken as a whole, or (F) any change resulting from compliance with terms of this Note or the consummation
of the transactions contemplated by this Note, or (iii) the Company’s ability to perform in any material respect on a timely basis
its obligations under this Note to be performed as of the date of determination.

(f) “”
means any other promissory notes issued by the Company to the Holder.

(g) “”
shall mean the Company’s (i) Annual Report on Form 20-F and(ii) any financial report to be filed on Form 6-K..

(h) “”
means a corporation, an association, a partnership, organization, a business, an individual, a government or political subdivision thereof
or a governmental agency.

(i) “”
shall mean any trading tier of The Nasdaq Stock Market LLC; provided however, that in the event the ADSs are ever listed or traded on
the New York Stock Exchange, or the NYSE American, then the “Principal Market” shall mean